Eyegate Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Premarket Biotech Digest – BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1
Article By: KKD Healthcare Analytics
Monday, April 24, 2017 10:03 AM EDT
Johnson & Johnson announced results from a Phase 2 clinical trial assessing the triple combination ofOlysio (simeprevir), C.R. Bard Inc. and Becton Dickinson finalize the deal for buying Bard.
In this article: BCR, JNJ, MRK, NVO, VNLPF, XOMA, EYEG, ARGNF, BDX
Read
Eyegate Announces Completion Of $3.77 Million Registered Direct Offering
Article By: NASDAQ GlobeNewswire
Thursday, June 30, 2016 5:39 PM EDT
EyeGate Pharmaceuticals, Inc.today announced the completion of its previously announced offering of the Company’s common stock and of Series A Convertible Preferred Stock for aggregate gross proceeds of approximately $3.77 million.
In this article: EYEG
Read
All Posts

Latest Tweets for $EYEG

No tweets yet!

PARTNER HEADLINES